BREAKING NEWS: DOL Finalizes PBM Fee Disclosure Rule — A Major Step Forward for Health Plan Fiduciary Transparency
October 30, 2026 | Greenleaf Advisors — Regulatory Update
The U.S. Department of Labor has finalized its long-awaited rule, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure, marking another significant step toward greater transparency and accountability in employer-sponsored healthcare.
The rule is designed to give health plan fiduciaries greater visibility into how pharmacy benefit managers (PBMs) and their affiliates are compensated, including compensation arrangements that may not be apparent in traditional service agreements.
The central message is simple: Plan fiduciaries need sufficient information to determine whether PBM compensation is reasonable—and the ability to monitor that compensation over time.
What’s Changing?
The final rule establishes more detailed disclosure and oversight requirements for PBMs and certain affiliated service providers serving large self-insured group health plans.
Key provisions include:
- Greater compensation transparency: Disclosure of direct and indirect compensation, including manufacturer payments, spread compensation, pharmacy clawbacks, and other financial arrangements.
- Ongoing reporting: Initial compensation disclosures before entering into, renewing, or extending service arrangements, followed by reporting of actual compensation.
- Audit rights: Plan fiduciaries will have the ability to obtain independent verification of disclosed compensation information.
- Greater accountability: Requirements intended to help fiduciaries identify discrepancies, understand potential conflicts of interest, and evaluate whether compensation is reasonable.
These changes provide employers with additional tools to better understand the financial arrangements underlying their pharmacy benefit programs.
An Important Clarification for Fully Insured Plans
Although the final rule’s detailed PBM disclosure requirements focus on large self-insured group health plans, the DOL also makes an important clarification:
Fully insured group health plans remain subject to the statutory compensation disclosure provisions under ERISA Section 408(b)(2)(B).
In other words, exclusion from the new detailed PBM rule does not eliminate the underlying statutory disclosure obligations applicable to covered service providers serving fully insured plans.
The Fiduciary Takeaway: Transparency Is Only the Beginning
The DOL’s final rule reinforces something we’ve been saying for years:
You cannot fulfill your fiduciary responsibilities if you don’t have the information necessary to make prudent decisions.
But here’s the important distinction: Obtaining the information is only the first step. What you do with it is what matters.
Are employers reviewing compensation arrangements? Asking questions? Understanding potential conflicts of interest? Comparing costs? Documenting their decisions?
We’ve seen this evolution before in the retirement plan industry. Fee transparency was a critical turning point, but it was the fiduciary process that followed that ultimately drove greater accountability.
Healthcare is moving in that same direction.
The opportunity for employers is significant. Greater access to compensation information can help them better understand where healthcare dollars are going, challenge arrangements that may not serve the plan’s best interests, and strengthen oversight of their service providers.
Transparency creates visibility. Prudence requires action. And documentation demonstrates the process.
The question for employers is no longer just whether they have access to the information. It’s whether they have a process in place to evaluate it and act on what they find.
